Cargando…
Current and Novel Alkylators in Multiple Myeloma
SIMPLE SUMMARY: In this review we have summarized the history, the current use, and the future possibilities of alkylator treatment in multiple myeloma. Alkylators have for decades been part of the standard of care of myeloma treatment, but still new alkylators and new use of old alkylators are maki...
Autores principales: | Schjesvold, Fredrik, Oriol, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158783/ https://www.ncbi.nlm.nih.gov/pubmed/34070213 http://dx.doi.org/10.3390/cancers13102465 |
Ejemplares similares
-
Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
por: Raab, Marc S., et al.
Publicado: (2023) -
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
por: Bobin, Arthur, et al.
Publicado: (2020) -
Current Main Topics in Multiple Myeloma
por: Morè, Sonia, et al.
Publicado: (2023) -
The role of idecabtagene vicleucel in patients with heavily
pretreated refractory multiple myeloma
por: Oriol, Albert, et al.
Publicado: (2021) -
P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALIDOMIDE–PRETREATED MULTIPLE MYELOMA: A SUBANALYSIS OF OPTIMISMM BY FRAILTY
por: Oriol, A., et al.
Publicado: (2022)